[1] Mamedov V.A., “
Quinoxalines”,1st ed. Springer, AG Switzerland (2016).
[5] Lindsley C.W., Zhao Z., Leister W.H., Robinson R.G., Barnell S.F., Defeozones D., Jones R.E., Hartman G.D., Huff J.R., Huber H.E., Duggan M.E.,
Allosteric Akt (PKB) inhibitors: Discovery and SAR of Isozyme Selective Inhibitors, Bioorg. Med. Chem. Lett.,
15: 761-764 (2005).
[6] Sarges R., Howerd H.R., Browne R.C., Label L.A., Seymour P.A
., 4-Amino[1,2,4] Triazolo[4,3-a]quinoxalines: A Novel Class of Potent Adenosine Receptor Antagonists and Potential Rapid-Onset Antidepressants,
J. Med. Chem.,
33: 2240-2254 (1990).
[12] Guillon J., Philippe G., Labaied M., Sonnet P., Le`ger J.M., Poulain P.D., Bares I.F., Dallemagne P., Lemaitre N., Pehourcq F., Rochette J., Sergheraert C., Christian J.,
Synthesis, Antimalarial Activity, and Molecular Modeling of New pyrrolo[1,2-a]quinoxa lines, bispyrrolo[1,2-a]quinoxalines, Bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and Bispyrrolo[1,2-a]thieno[3,2-e] pyrazines,
J. Med. Chem.,
47: 1997-2009 (2004).
[14] DrillerK.M., LibnowS., HeinM., HarmsM., WendeK.,Lalk M., Michalik D., ReinkeH., Langer P
.,Synthesis of 6H-indolo[2,3-b]quinoxaline-N-Glycosides and Their Cytotoxic Activity Against Human Ceratinocytes (HaCaT), Org. Biomol. Chem.
6: 4218-4223 (2008).
[15] Harmenberg J., Akesson J.A., Graslund A., Malmfors T., Bergman J., Wahren B
., The Mechanism of Action of the Anti-Herpes Virus Compound 2,3-dimethyl-6(2 dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline, Antiviral Res.,
15: 193–204 (1991).
[61] Sajjadifar S., Zolfigol M.A., Mirshokraie A., Miri S., Louie O., Rezaee Nezhad E., Karimian S., Darvishi G., Donyadari E., Farahmand S
., Facile Method of Quinoxaline Synthesis Using Phenol as a New, Efficient and Cheap Catalyst at Room Temperature,
Am. J. Org. Chem.,
2: 97-104 (2012).